In December 1995, I came home from an MRI and saw the answering machine blinking. The doctor had “found something.” That tiny cassette tape became the dividing line between the life I knew and the bewildering new world of being a patient.

Sydney Towle didn’t fail to look sick enough. We failed to understand what living with cancer can actually look like. Her story exposes a culture that demands patients perform suffering before offering compassion, and what that says about all of us.

At the 2026 Robert A. Winn Clinical Investigator Symposium, hundreds of medical students received We the Patients and were challenged to see healthcare from the patient side of the bed rail, including the burden, bureaucracy, and hidden labor that medical training too often ignores.

OncoDaily named 100 influential cancer survivors for 2026. Matthew Zachary explains why the honor matters, why it’s bittersweet, and what survivor visibility really means for newly diagnosed patients looking for proof they’re not alone.

Brain cancer at 21 forced Matthew Zachary into the American healthcare system decades before he understood its economics, incentives, and failures. At 52, he reflects on how surviving long enough to see the whole machine clearly led to writing We the Patients.

Cancer patients increasingly absorb the financial risk of surviving disease in America. A brain cancer survivor examines how healthcare incentives, insurance design, and policy decisions shifted instability onto patients and families while institutions protect margins.

We the Patients officially launches today and is already in its second printing before release day. Matthew Zachary shares why readers across healthcare, advocacy, and survivorship circles are responding so strongly to a book that names the realities patients live through every day.

Millions of eczema patients increasingly distrust the treatments medicine tells them to rely on. Matthew Zachary examines topical steroid withdrawal, chronic inflammation, patient distrust, and the healthcare incentives driving one of medicine’s fastest growing credibility crises

A 30 year brain cancer survivor breaks down how insurance delays, denials, and red tape harm patients by design. This is not dysfunction. This is the business model.